39 results on '"Singh, Nina"'
Search Results
2. Association of Cytomegalovirus (CMV) DNAemia With Long-Term Mortality in a Randomized Trial of Preemptive Therapy and Antiviral Prophylaxis for Prevention of CMV Disease in High-Risk Donor Seropositive, Recipient Seronegative Liver Transplant Recipients
3. Unexpected Cytomegalovirus (CMV) Replication Kinetics in CMV Donor-Seropositive, Recipient-Seronegative Liver Transplant Recipients Receiving Preemptive Antiviral Therapy
4. Risk Factors for Cytomegalovirus Viremia following Liver Transplantation With a Seropositive Donor and Seronegative Recipient Receiving Antiviral Therapy
5. Cost-effectiveness of Preemptive Therapy Versus Prophylaxis in a Randomized Clinical Trial for the Prevention of Cytomegalovirus Disease in Seronegative Liver Transplant Recipients With Seropositive Donors
6. Cytomegalovirus Infection in Solid Organ and Hematopoietic Cell Transplantation: State of the Evidence
7. Unique Rarity of Tuberculosis and Granulomatous Opportunistic Infections in Hematopoietic Cell Transplant Recipients
8. Prospective Assessment of Cytomegalovirus Immunity in High-Risk Donor-Seropositive/Recipient-Seronegative Liver Transplant Recipients Receiving Either Preemptive Therapy or Antiviral Prophylaxis
9. LB21. Preemptive Therapy (PET) vs. Prophylaxis for Prevention of Cytomegalovirus (CMV) Disease in High-Risk Donor Seropositive/Recipient Seronegative (D+R−) Liver Transplant Recipients (LTR): A NIH-Sponsored, Randomized, Controlled, Multicenter Trial
10. Unique characteristics of cryptococcosis identified after death in patients with liver cirrhosis: comparison with concurrent cohort diagnosed antemortem
11. Antifungal Prophylaxis in Liver Transplant Recipients
12. Unrecognized Pretransplant and Donor‐Derived Cryptococcal Disease in Organ Transplant Recipients
13. Cutaneous cryptococcosis in solid organ transplant recipients
14. Reply to Soonawala et al
15. Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America
16. Lipid Formulations of Amphotericin B Significantly Improve Outcome in Solid Organ Transplant Recipients with Central Nervous System Cryptococcosis
17. Zygomycosis in Solid Organ Transplant Recipients: A Prospective, Matched Case‐Control Study to Assess Risks for Disease and Outcome
18. Reply to Galgóczy et al
19. Cryptococcosis in Solid‐Organ, Hematopoietic Stem Cell, and Tissue Transplant Recipients: Evidence‐Based Evolving Trends
20. Antimicrobial and Immunomodulatory Attributes of Statins: Relevance in Solid‐Organ Transplant Recipients
21. Invasive mould infections: a multi-disciplinary update
22. Immunocompromised Hosts: Cryptococcosis in Solid Organ Transplant Recipients: Current State of the Science
23. Clinical Research in the Lay Press: Irresponsible Journalism Raises a Huge Dose of Doubt
24. Late-onset invasive aspergillosis in organ transplant recipients in the current era
25. Antifungal Prophylaxis in Solid-Organ Transplant Recipients: Considerations for Clinical Trial Design
26. Trends in Risk Profiles for and Mortality Associated with Invasive Aspergillosis among Liver Transplant Recipients
27. The Impact of Novel Immunosuppressive Agents on Infections in Organ Transplant Recipients and the Interactions of These Agents with Antimicrobials
28. Reply
29. Trends in the Epidemiology of Opportunistic Fungal Infections: Predisposing Factors and the Impact of Antimicrobial Use Practices
30. Control of an Outbreak of Infection Due to Extended‐Spectrum β‐Lactamase–ProducingEscherichia coliin a Liver Transplantation Unit
31. Adherence of Human Immunodeficiency Virus–Infected Patients to Antiretroviral Therapy
32. Fatal Infection Due to Extended‐Spectrum Beta‐Lactamase‐Producing Escherichia coli: Implications for Antibiotic Choice for Spontaneous Bacterial Peritonitis
33. Mycobacterium tuberculosisInfection in Solid‐Organ Transplant Recipients: Impact and Implications for Management
34. Answer to Photo Quiz I
35. Infective Endocarditis in Solid Organ Transplant Recipients
36. Fever in Liver Transplant Recipients: Changing Spectrum of Etiologic Agents
37. Rapidly Fatal Bacteremia Due to Staphylococcus aureus Producing Both Enterotoxins A and B in a Liver Transplant Recipient
38. Interactions Between Tacrolimus and Antimicrobial Agents
39. Cirrhotic Fever in the 1990s: A Prospective Study with Clincal Implications
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.